Aesthetic Injectables | Market Insights | Asia Pacific | 2023
Although the COVID-19 pandemic significantly impacted the Asia Pacific aesthetic injectable market in the short term, the market will grow rapidly through 2031. The market continues to see recovery following the negative impact of the COVID-19 pandemic. An expanding patient pool—namely emerging patient groups, such as men and younger people—will fuel procedure volumes over the forecast period. New advancements and differentiated products from competitors in the market will also support continued demand for aesthetic injectables.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aesthetic injectables (including BTX and dermal fillers) in the Asia Pacific region from 2019 through 2031.
